| Market Size in 2024 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 13.25 Billion | USD 26.48 Billion | 8.00% | 2023 |
This report is based on in-depth qualitative and quantitative analyses of the global Polymerase Chain Reaction (PCR) market. Zion Market Research has collected and analyzed key data belong to the global Polymerase Chain Reaction (PCR) market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.
The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.
Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Polymerase Chain Reaction (PCR) across the world has been calculated through primary and secondary research.
Zion Market Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc.
For this study, Zion Market Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Polymerase Chain Reaction (PCR) industry. Primary research makes up the major source of data collection and validation.
Primary Research
We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:
Participants who typically participate in such a process include, but are not limited to:
Key opinion leaders specializing in different areas corresponding to different industry verticals
Secondary Research
Secondary research sources that are typically referred to include, but are not limited to:
News articles, press releases, and webcasts specific to companies operating in the market
Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Polymerase Chain Reaction (PCR) market.
Models
Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:
FrequentlyAsked Questions
A prevalent molecular biology method, Polymerase Chain Reaction (PCR) enables the amplification of a particular DNA segment. Since its inception in 1983 by Kary Mullis, PCR has emerged as an indispensable instrument in a vast array of biological and biomedical contexts. The procedure entails enzymatic amplification of a specific segment of target DNA, which generates a substantial number of copies of that segment.
Market expansion can be stimulated by continuous developments in polymerase chain reaction (PCR) technologies, including the creation of innovative enzymes, enhanced reagents, and more effective thermal cyclers, which improve the performance and dependability of PCR assays. The expanding scientific applications of PCR, such as in the fields of genomics, transcriptomics, and epigenetics, contribute to the expansion of the market. PCR is an indispensable instrument in numerous molecular biology investigations.
The global polymerase chain reaction (PCR) market size was worth around USD 13.25 billion in 2023 and is predicted to grow to around USD 26.48 billion by 2032.
The global polymerase chain reaction (PCR) market with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.
Regional segmentation comprises present and projected demand for the following regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This is further subdivided into significant countries such as the United States, United Kingdom, Germany, France, China, Japan, India, Brazil, and others. This segmentation encompasses the technological demand for polymerase chain reaction across all regions and countries.
The report also includes detailed profiles of end players such as Affymetrix, Inc., Agilent Technologies, Inc., Sigma Aldrich Corporation, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, GE Healthcare, QIAGEN, Becton Dickinson & Company and Thermo Fischer Scientific.
HappyClients